Telocyte
Peter Rayson is a seasoned leader with extensive experience in various sectors, including therapeutics, health technology, and synthetic biology, currently serving as a General Partner at Pharma Capital Partners since March 2022. As CEO of Telocyte since January 2015, Rayson focuses on combating age-related diseases, particularly Alzheimer's disease. Rayson also holds a Non-Executive Director position at Greenworks Tools, a leader in cordless products. Prior roles include Associate Dean at Birmingham City University, Associate Director at the Technology Innovation Centre, and Senior Fellow at Warwick Manufacturing Group. Rayson has a strong background in strategic consulting, industry marketing, and aerospace operations, previously holding senior positions at PTC and Computervision. Rayson holds a Master’s degree in Manufacturing Technology from The University of Manchester and a Bachelor's degree in Mechanical Sciences/Control Systems from the University of Wales Institute of Science and Technology.
This person is not in any teams
This person is not in any offices
Telocyte
We are a biotechnology company dedicated to curing Alzheimer's disease. We are planning FDA-sponsored human trials, using telomerase therapy to reset cell aging within the central nervous system. We believe that Alzheimer's disease can stopped, prevented, and cured.